Aurinia Pharmaceuticals (AUPH) Research & Development (2018 - 2025)
Historic Research & Development for Aurinia Pharmaceuticals (AUPH) over the last 9 years, with Q3 2025 value amounting to $8.4 million.
- Aurinia Pharmaceuticals' Research & Development rose 17682.97% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year increase of 2973.46%. This contributed to the annual value of $20.8 million for FY2024, which is 5812.94% down from last year.
- According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Research & Development is $8.4 million, which was up 17682.97% from $7.4 million recorded in Q2 2025.
- In the past 5 years, Aurinia Pharmaceuticals' Research & Development ranged from a high of $20.1 million in Q3 2021 and a low of $3.0 million during Q3 2024
- Over the past 5 years, Aurinia Pharmaceuticals' median Research & Development value was $9.9 million (recorded in 2022), while the average stood at $9.4 million.
- As far as peak fluctuations go, Aurinia Pharmaceuticals' Research & Development surged by 22895.0% in 2023, and later crashed by 7760.38% in 2024.
- Over the past 5 years, Aurinia Pharmaceuticals' Research & Development (Quarter) stood at $11.1 million in 2021, then decreased by 11.47% to $9.9 million in 2022, then increased by 3.63% to $10.2 million in 2023, then decreased by 20.74% to $8.1 million in 2024, then rose by 4.05% to $8.4 million in 2025.
- Its Research & Development stands at $8.4 million for Q3 2025, versus $7.4 million for Q2 2025 and $5.7 million for Q1 2025.